Supervised Exercise-training in Children With Insulin Resistance or Healthy Metabolic Profile

NCT03003754 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2018-10-15

No results posted yet for this study

Summary

Despite exercise training decrease blood fasting glycemia in 'average' terms, there is a wide interindividual variability after exercise training explored mainly in adults but not in children. Thus, is yet unknown what baseline health status as well as the influence of what health variable may produce more/less non-responder (NR) prevalence (i.e., percentage of subjects who experienced a non-change/worsened response after training in some metabolic outcomes) after exercise training in school children.

Conditions

  • Metabolism Disorder
  • Insulin Sensitivity
  • Obesity, Pediatric

Interventions

BEHAVIORAL

High Intensity Training (HIT) + Resistance Training (RT)

Exercise will be performed at three sessions per week. Post statistical analyses will be including analyses by the 3 sub-groups proposed. All sessions will be supervised by an exercise physiologist during 6 weeks.

BEHAVIORAL

Control group

Post statistical analyses will be including analyses by the 3 sub-groups proposed Exercise will be performed at three sessions per week. All sessions will be supervised by an exercise physiologist during 6 weeks.

Sponsors & Collaborators

  • Healthcare Center Tomas Rojas

    collaborator OTHER
  • Health Service of Los Ríos by the Health promotion program

    collaborator UNKNOWN
  • Universidad Pública de Navarra

    collaborator OTHER
  • Universidad del Rosario

    collaborator OTHER
  • Universidad Santo Tomas

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
9 Years
Max Age
13 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2016-12-31
Completion
2017-02-28

Countries

  • Colombia

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03003754 on ClinicalTrials.gov